- Forums
- ASX - By Stock
- Ann: Kazia releases final data from P2 paxalisib trial
Enough to trigger a Priority Review Voucher from the FDA ?
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)